Study Title: A randomized, double-blind, placebo-controlled, multicenter phase 2 study of AK117/placebo in combination with azacitidine in patients with newly diagnosed higher-risk myelodysplastic syndromes
This trial is closed to accrual. For general questions, please contact the Clinical Trials Office.